Showing results (141-150 of 219) with videos related to
Sort By:
Pageof 22
Cancer|February 11, 2025
Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505Sameer H Patel, Sarah Colby, Davendra Sohal, et al.Journal of Ovarian Research|November 15, 2024
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumorsMary P Udumula, Faraz Rashid, Harshit Singh, et al.Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.American Journal of Clinical Oncology|December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II studySana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.Surgery|September 5, 2012
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101Aamer M Qazi, Oksana Gruzdyn, Assaad Semaan, et al.Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.Gastrointestinal Cancer Research : GCR|November 1, 2012
A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancerCaio M Rocha Lima, Edward H Lin, George P Kim, et al.Pageof 22